21 CFR Part 11 and Sales Enablement: What Actually Applies

Does 21 CFR Part 11 apply to sales enablement software?

Usually, no. 21 CFR Part 11 governs electronic records and electronic signatures that a predicate rule already requires you to keep. It does not apply to every piece of software an FDA-regulated company happens to own. A platform that distributes approved brochures, spec sheets, and eDetailers to a field team is delivering content — it is not the regulated record.

The system that holds the regulated record is typically your content management or regulatory system of record. That is where the approval record lives, that is where validation is performed, and that is where Part 11 attaches. Your enablement layer sits downstream of it.

This is why the question is worth getting right before you spend money on it. Pulling a content delivery tool into Part 11 scope unnecessarily does not make you more compliant. It makes you slower, and it puts a validation burden on a system that was never the record in the first place.

What 21 CFR Part 11 actually governs

Part 11 sets the conditions under which the FDA will accept an electronic record or electronic signature as equivalent to paper and ink. Its core requirements include:

• Validation of the system for its intended use (§11.10(a))
• Secure, computer-generated, time-stamped audit trails that never obscure previously recorded values (§11.10(e))
• Access and authority checks — unique, attributable user identities (§11.10(d), (g))
• Signature manifestation — the signed record must display the signer’s printed name, the date and time, and the meaning of the signature (§11.50)
• Signature-to-record linking, so a signature cannot be excised, copied, or transferred to another record (§11.70)
• Two-component electronic signatures and controls over identification codes and passwords (§11.200, §11.300)

Critically, §11.100(c) requires the regulated company — not the software vendor — to certify to the FDA that its electronic signatures are the legally binding equivalent of handwritten ones. No vendor can do that for you.

Where the line is: when your enablement tool does come into scope

Part 11 attaches to the tool, not the category. A sales enablement platform can be pulled into scope if you use it to capture a record that a predicate rule requires. The three most common triggers:

1. Electronic signature capture on drug sample receipts

The Prescription Drug Marketing Act requires a signed receipt when samples change hands. Capture that signature on a tablet instead of paper, and Part 11 applies to how it was captured, stored, and linked. This is the single most common way a field tool ends up in scope.

2. Approval workflows treated as the record of approval

If your MLR or promotional review approval is recorded in the enablement platform — rather than mirrored from a validated system upstream — the enablement platform is now holding a GxP record.

3. Training acknowledgments used as GxP training records

A “read and understood” click is fine as an engagement metric. It is a regulated record the moment you rely on it to demonstrate trained-personnel requirements to an inspector.

If none of these describe your deployment, Part 11 is almost certainly not your enablement platform’s problem — and any vendor implying otherwise is selling you something you do not need.

Where vablet stands

vablet is not 21 CFR Part 11 certified, because no software is. We would rather tell you that plainly than let you discover it during a vendor audit.

What vablet does hold is a set of certifications that are independently meaningful, and that we are glad to put in front of your security and quality teams:

• HIPAA — vablet supports the usage and distribution of your HIPAA-regulated content. This is the certification that most matters to medical device and pharmaceutical field teams, and it is one that several major enablement platforms do not claim at all.
• ISO 27001 — the international standard for information security management.
• SOC 2 — security, availability, processing integrity, confidentiality, and privacy.
• GDPR — for your European operations.

Platform controls that support your validation

Beyond those certifications, vablet provides platform controls that map directly to the technical safeguards Part 11 describes — the same controls your quality team would evaluate if a specific workflow ever did come into scope:

• Time-stamped audit trails — user and content activity is recorded, so you can see who accessed and acted on content, and when (relevant to §11.10(e)).
• Encryption — your data is encrypted in transit and at rest.
• Single sign-on (SSO) — vablet integrates with your identity provider, so access follows your existing authentication and deprovisioning controls.
• Unique user identities — every user has an individual account, so actions are attributable to a named person rather than a shared device or login (relevant to §11.10(d) and (g)).

These are controls vablet provides; validation for your intended use remains yours. The difference is that vablet gives your regulated workflows a defensible starting point rather than a gap to explain.

Compliance is one of the things that sets vablet apart. We are a trusted, validated enterprise platform that scales from large multinational operations down to small medical device distributors — and a ten-person distributor runs on the same certified infrastructure as a global manufacturer. Compliance is not an enterprise-tier upsell here.

If your quality or regulatory team needs to work through where Part 11 sits in your specific architecture, we will have that conversation with you honestly, including the parts where the answer is “that belongs in your system of record, not in ours.”

See our full compliance certifications, or how we support pharmaceutical and medical device sales teams and other regulated environments.